NCT04393922

Brief Summary

Very often, people who have a SCI have difficulty doing things with their arms or hands as a result of muscle stiffness , or spasticity. Spastacity can cause problems performing even the simplest of everyday tasks. This research will help us understand how the body recovers and changes neurologically after SCI.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 13, 2020

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

May 14, 2020

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 19, 2020

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 18, 2023

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 18, 2024

Completed
Last Updated

June 22, 2022

Status Verified

June 1, 2022

Enrollment Period

3.1 years

First QC Date

May 14, 2020

Last Update Submit

June 20, 2022

Conditions

Keywords

Spinal cord injury, Spasticity, TMS

Outcome Measures

Primary Outcomes (10)

  • MEP recruitment curves

    Ten stimuli (0.2 Hz) will be delivered at each intensity to plot the mean peak-to-peak amplitude of the MEP from the non-rectified response against the TMS intensity in each subject (MEP recruitment curve).

    3-4 hours

  • Ipsilateral MEPs (iMEPs)

    Ten stimuli will be delivered during head straight and ten stimuli will be delivered during lateral head rotation, randomly alternated (0.2 Hz).

    3-4 hours

  • StartReact

    Here, participants will be asked to observe a light-emitting diode (LED) located in front of their head. When the LED will illuminate, individuals will be asked to move their arm or leg. In some trials, the LED will be presented with either a quiet acoustic stimulus (80 dB, 500 Hz, 50 ms) or a startling acoustic stimulus (SAS, 120 dB, 500 Hz, 50 ms) delivered through a headphone.

    3-4 hours

  • Participant reported spasticity

    Spasticity questionnaire

    3-4 hours

  • Modified Ashworth Scale (MAS)

    This scale measures resistance encountered during manual passive muscle stretching using a six-point ordinal scale.

    3-4 hours

  • Portable Spasticity Assessment Device (PSAD)'

    The PSAD combine biomechanical and electrophysiological measurements for an objective quantification of active and passive component of muscle stiffness

    3-4 hours

  • Pendulum Test

    As part of the physical exam, we will use the pendulum test to measure muscle tone at the knee by using gravity to provoke muscle stretch reflexes during passive swinging of the lower limb.

    3-4 hours

  • 10-meter walk test

    10-meter walk test will be used to assess walking speed

    3-4 hours

  • Graded and Redefined Assessment of Strength, Sensibility and Prehension (GRASSP).

    This exam measures clinical impairment that incorporates three domains vital to upper-limb function: sensation, strength, and prehension.

    3-4 hours

  • Toronto Rehabilitation Institute-Hand Function Test (TRI-HFT)

    This exam measures gross motor function frequently used to manipulate objects that participants may encounter in their daily lives.

    3-4 hours

Study Arms (2)

Aim 1

EXPERIMENTAL

To accomplish this aim, we will conduct one experiment in two sessions separated by 2- 3 days using a crossover design. Participants will be assigned into one of three groups: spastic SCI, non-spastic SCI, and controls. We expect that people enrolled in Aim 1 will complete 2 visits within 1 week. Visit 1 Measurements: * MVCs * MEP Recruitment Curves * iMEPs * StartReact Visit 2 Measurements: * Participant Reported Spasticity * MAS * PSAD * KINARM * MRI of brain and spinal cord

Behavioral: Acoustic stimuli (Startle)

Aim 2

EXPERIMENTAL

To accomplish this aim, we will use a randomized crossover design study with spastic SCI participants receiving a single intervention combining non-invasive acoustic stimuli (Startle) or sham-Startle with motor training to enhance cortico- and reticulo-spinal contribution, separated by \~2 weeks. Visit 1 and Visit 2 Single intervention of: Startle + exercise training OR sham-Startle + exercise training Pre and post measurements: * MVCs * MEP recruitment curves * iMEPs * StartReact * Participant reported spasticity * MAS * PSAD * KINARM * Neuromechanical hand and/or leg testing * GRASSP * TRI-HFT * 10-meter walk test * Pendulum Test

Behavioral: Acoustic stimuli (Startle)

Interventions

A startle stimulus (120 dB, 500 Hz, 50 ms) will be delivered through headphones

Aim 1Aim 2

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Chronic SCI (≥1 year of injury)
  • Incomplete spinal cord injury at T12 or above
  • Males and Females
  • Ages 18-75 years
  • MAS scores of 0 and 1
  • MAS scores of 2, 3 and 4
  • The ability to perform a voluntary flexion and extension of the elbow and/or knee or ankle
  • The ability to reach and grasp an object
  • Males and females
  • Ages 18-75 years
  • Right-handed
  • Able to perform elbow and/or knee or ankle flexion and extension

You may not qualify if:

  • Uncontrolled medical problems including pulmonary, cardiovascular, or orthopedic disease
  • Any debilitating disease prior to the SCI that caused exercise intolerance
  • Premorbid, ongoing major depression or psychosis, altered cognitive status
  • History of head injury or stroke
  • Pacemaker
  • Metal plate in skull
  • History of seizures
  • Receiving drugs acting primarily on the central nervous system, which lower the seizure threshold such as antipsychotic drugs (chlorpromazine, clozapine) or tricyclic antidepressants
  • Pregnant females
  • Ongoing cord compression or a syrinx in the spinal cord or who suffer from a spinal cord disease such as spinal stenosis, spina bifida, or herniated cervical disk

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shirley Ryan AbilityLab

Chicago, Illinois, 60611, United States

RECRUITING

MeSH Terms

Conditions

Spinal Cord InjuriesMuscle Spasticity

Condition Hierarchy (Ancestors)

Spinal Cord DiseasesCentral Nervous System DiseasesNervous System DiseasesTrauma, Nervous SystemWounds and InjuriesMuscular DiseasesMusculoskeletal DiseasesMuscle HypertoniaNeuromuscular ManifestationsNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Central Study Contacts

Sina Sangari, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Scientific Chair Arms + Hands Lab

Study Record Dates

First Submitted

May 14, 2020

First Posted

May 19, 2020

Study Start

May 13, 2020

Primary Completion

June 18, 2023

Study Completion

May 18, 2024

Last Updated

June 22, 2022

Record last verified: 2022-06

Data Sharing

IPD Sharing
Will not share

Locations